SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-008450
Filing Date
2020-02-11
Accepted
2020-02-11 18:27:21
Documents
2
Period of Report
2020-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1579
2 EX-24 DOCUMENT attachment1.htm EX-24 3315
  Complete submission text file 0001209191-20-008450.txt   6296
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Issuer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Patni Rajiv (Reporting) CIK: 0001616200 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35935 | Film No.: 20598598